跳至主要内容
临床试验/NCT07077265
NCT07077265已完成不适用

Comparing Two Different Norepinephrine Infusion Rates for Prophylaxis Against Spinal-induced Hypotension in Elderly Patients Undergoing Hip Surgery: A Randomized Controlled Non-inferiority Trial

Kasr El Aini Hospital1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2025年8月1日最近更新:
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
84
试验地点
1
主要终点
mean arterial pressure

研究概览

简要总结

The current study aims to determine whether norepinephrine infusion rate (0.07 mcg/kg/min) is non-inferior to the higher dose (0.1 mcg/kg/min) in maintaining intraoperative blood pressure maintaining blood pressure of elderly patients during hip surgery

详细描述

Baseline preoperative blood pressure will be recorded in the supine position as average of 3 reading with difference less than 5 mmHg in the mean arterial pressure.

Inferior vena cava collapsibility will be used to assess the patient's intravascular volume status.

After induction of spinal anesthesia, patients will receive the vasopressor infusion according to the previous randomization All drug preparations will be done by a research assistant who will be responsible for opening the envelope and group assignment with no further involvement in the study.

Any episode of hypotension (defined as mean arterial pressure (MAP) < 70% of the baseline or MAP<65mmHg) will be managed by 5 mcg norepinephrine.

If bradycardia (defined as heart rate less than 50 bpm) with hypotension occurred, it will be manged with 9 mg ephedrine. If bradycardia occurred with hypertension (MAP increase 20% over the baseline) and persisted for more than one reading, the vasopressor infusion will be stopped.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Elderly patients (>65)
  • ASA I-II-III
  • scheduled for hip surgery under spinal anesthesia

排除标准

  • Contraindication of spinal anesthesia
  • history of allergy to any of the study's drugs,
  • Patients with cardiac morbidities (impaired contractility with ejection fraction < 50%, heart block, arrhythmias)
  • patients with uncontrolled hypertension

研究组 & 干预措施

NE 0.1 mcg

Active Comparator

norepinephrine infusion rate of 0.1 mcg/kg/min

干预措施: Norepinephrine (0.1 μg/kg/min) (Drug)

NE 0.07 mcg

Active Comparator

norepinephrine infusion rate of 0.07 mcg/kg/min

干预措施: Norepinephrine (0.07 μg/kg/min) (Drug)

结局指标

主要结局

mean arterial pressure

时间窗: 0 min after spinal anesthesia till 46 min after spinal anesthesia

average mean arterial pressure

次要结局

  • incidence of hypotension(0 min after spinal anesthesia till 46 min after spinal anesthesia)
  • incidence of reactive hypertension(0 min after spinal anesthesia till 46 min after spinal anesthesia)
  • incidence of bradycardia(0 min after spinal anesthesia till 46 min after spinal anesthesia)

研究者

发起方
Kasr El Aini Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maha Mostafa Ahmad, MD

assistant professor

Kasr El Aini Hospital

研究点 (1)

Loading locations...

相似试验